{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:10:20Z","timestamp":1788801020683,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Life Science Academy","award":["No.2025600CB0050"],"award-info":[{"award-number":["No.2025600CB0050"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82372885"],"award-info":[{"award-number":["No. 82372885"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical New Technology and New Therapy Project of Peking University School of Stomatology","award":["PKUSSNCT-23B05"],"award-info":[{"award-number":["PKUSSNCT-23B05"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["No. 2022YFC2504200"],"award-info":[{"award-number":["No. 2022YFC2504200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["No. 2024YFF0507401"],"award-info":[{"award-number":["No. 2024YFF0507401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic Science Center Program of the National Natural Science Foundation of China","award":["No. T2288102"],"award-info":[{"award-number":["No. T2288102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-05003-7","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:30:24Z","timestamp":1782127824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Matrigel\/serum-free, high-fidelity patient-derived tumor-like cell clusters as an in vitro platform for large-scale compound screening and chemoresistance prediction in oral cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Yufeng","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixiang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huinan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong Jeff","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"5003_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.oraloncology.2018.10.013","volume":"87","author":"AK D\u2019Cruz","year":"2018","unstructured":"D\u2019Cruz AK, Vaish R, Dhar H. Oral cancers: current status. Oral Oncol. 2018;87:64\u201369.","journal-title":"Oral Oncol"},{"key":"5003_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15:44.","journal-title":"Int J Oral Sci"},{"key":"5003_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","volume":"382","author":"LQM Chow","year":"2020","unstructured":"Chow LQM. Head and neck cancer. N Engl J Med. 2020;382:60\u201372.","journal-title":"N Engl J Med"},{"key":"5003_CR4","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.3390\/cancers14246079","volume":"14","author":"MN Amaral","year":"2022","unstructured":"Amaral MN, Fa\u00edsca P, Ferreira HA, Gaspar MM, Reis CP. Current insights and progress in the clinical management of head and neck cancer. Cancers (Basel). 2022;14:6079.","journal-title":"Cancers (Basel)"},{"key":"5003_CR5","first-page":"189","volume":"50","author":"M Umeda","year":"2004","unstructured":"Umeda M, Komatsubara H, Ojima Y, Minamikawa T, Shigeta T, Shibuya Y, et al. Lack of survival advantage in patients with advanced, resectable squamous cell carcinoma of the oral cavity receiving induction chemotherapy with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU). Kobe J Med Sci. 2004;50:189\u201396.","journal-title":"Kobe J Med Sci"},{"key":"5003_CR6","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1002\/cam4.5075","volume":"12","author":"JY Fu","year":"2023","unstructured":"Fu JY, Yue XH, Dong MJ, Li J, Zhang CP. Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer. Cancer Med. 2023;12:2417\u201326.","journal-title":"Cancer Med"},{"key":"5003_CR7","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1097\/JS9.0000000000000489","volume":"109","author":"Y Huang","year":"2023","unstructured":"Huang Y, Sun J, Li J, Zhu D, Dong M, Dou S, et al. Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial). Int J Surg. 2023;109:2220\u20137.","journal-title":"Int J Surg"},{"key":"5003_CR8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1200\/JCO.2012.43.8820","volume":"31","author":"LP Zhong","year":"2013","unstructured":"Zhong LP, Zhang CP, Ren GX, Guo W, William WN Jr, Sun J, et al. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol. 2013;31:744\u201351.","journal-title":"J Clin Oncol"},{"key":"5003_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00764-x","volume":"8","author":"H Zhang","year":"2024","unstructured":"Zhang H, Qian Y, Zhang Y, Zhou X, Shen S, Li J, et al. Multi-omics analysis deciphers intercellular communication regulating oxidative stress to promote oral squamous cell carcinoma progression. NPJ Precis Oncol. 2024;8:272.","journal-title":"NPJ Precis Oncol"},{"key":"5003_CR10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/jpm13111618","volume":"13","author":"E Freitas de Morais","year":"2023","unstructured":"Freitas de Morais E, Siquara da Rocha LO, de Souza Santos JL, Freitas RD, Souza B, Coletta RD, et al. Use of three-dimensional cell culture models in drug assays for anti-cancer agents in oral cancer: protocol for a scoping review. J Pers Med. 2023;13:1618.","journal-title":"J Pers Med"},{"key":"5003_CR11","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.3390\/ijms21249520","volume":"21","author":"RT Chitturi Suryaprakash","year":"2020","unstructured":"Chitturi Suryaprakash RT, Kujan O, Shearston K, Farah CS. Three-dimensional cell culture models to investigate oral carcinogenesis: a scoping review. Int J Mol Sci. 2020;21:9520.","journal-title":"Int J Mol Sci"},{"key":"5003_CR12","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/jpm13111575","volume":"13","author":"I Arutyunyan","year":"2023","unstructured":"Arutyunyan I, Jumaniyazova E, Makarov A, Fatkhudinov T. In vitro models of head and neck cancer: from primitive to most advanced. J Pers Med. 2023;13:1575.","journal-title":"J Pers Med"},{"key":"5003_CR13","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3390\/cells9112527","volume":"9","author":"I Demers","year":"2020","unstructured":"Demers I, Donkers J, Kremer B, Speel EJ. Ex vivo culture models to indicate therapy response in head and neck squamous cell carcinoma. Cells. 2020;9:2527.","journal-title":"Cells"},{"key":"5003_CR14","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.3390\/cancers13236076","volume":"13","author":"KC Lin","year":"2021","unstructured":"Lin KC, Ting LL, Chang CL, Lu LS, Lee HL, Hsu FC, et al. Ex vivo expanded circulating tumor cells for clinical anti-cancer drug prediction in patients with head and neck cancer. Cancers (Basel). 2021;13:6076.","journal-title":"Cancers (Basel)"},{"key":"5003_CR15","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1126\/scitranslmed.abo5987","volume":"14","author":"Z Gu","year":"2022","unstructured":"Gu Z, Yao Y, Yang G, Zhu G, Tian Z, Wang R, et al. Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy. Sci Transl Med. 2022;14:5987.","journal-title":"Sci Transl Med"},{"key":"5003_CR16","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.3390\/cancers12123743","volume":"12","author":"TW Lee","year":"2020","unstructured":"Lee TW, Lai A, Harms JK, Singleton DC, Dickson BD, Macann A, et al. Patient-derived xenograft and organoid models for precision medicine targeting of the tumour microenvironment in head and neck cancer. Cancers (Basel). 2020;12:3743.","journal-title":"Cancers (Basel)"},{"key":"5003_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.oraloncology.2018.10.018","volume":"87","author":"N Tanaka","year":"2018","unstructured":"Tanaka N, Osman AA, Takahashi Y, Lindemann A, Patel AA, Zhao M, et al. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Oral Oncol. 2018;87:49\u201357.","journal-title":"Oral Oncol"},{"key":"5003_CR18","doi-asserted-by":"publisher","unstructured":"Harnischfeger N, Szabo L, Kretzschmar K Establishment and characterization of patient-derived oral cancer organoids. Methods Mol Biol. 2025; https:\/\/doi.org\/10.1007\/7651_2024_594","DOI":"10.1007\/7651_2024_594"},{"key":"5003_CR19","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41416-023-02167-4","volume":"128","author":"BWMTJ Basnayake","year":"2023","unstructured":"Basnayake BWMTJ, Leo P, Rao S, Vasani S, Kenny L, Haass NK, et al. Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges. Br J Cancer. 2023;128:1807\u201318.","journal-title":"Br J Cancer"},{"key":"5003_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/cancers12010092","volume":"12","author":"K Tuomainen","year":"2019","unstructured":"Tuomainen K, Al-Samadi A, Potdar S, Turunen L, Turunen M, Karhemo PR, et al. Human tumor-derived matrix improves the predictability of head and neck cancer drug testing. Cancers (Basel). 2019;12:92.","journal-title":"Cancers (Basel)"},{"key":"5003_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz1723","volume":"12","author":"S Yin","year":"2020","unstructured":"Yin S, Xi R, Wu A, Wang S, Li Y, Wang C, et al. Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Sci Transl Med. 2020;12:eaaz1723.","journal-title":"Sci Transl Med"},{"key":"5003_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2024.03.008","volume":"31","author":"S Yin","year":"2024","unstructured":"Yin S, Yu Y, Wu N, Zhuo M, Wang Y, Niu Y, et al. Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer. Cell Stem Cell. 2024;31:717\u2013733.e8.","journal-title":"Cell Stem Cell"},{"key":"5003_CR23","doi-asserted-by":"publisher","first-page":"101990","DOI":"10.1016\/j.xcrm.2025.101990","volume":"6","author":"T Gao","year":"2025","unstructured":"Gao T, He X, Wang J, Liu J, Hu X, Bai C, et al. Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomas. Cell Rep Med. 2025;6:101990.","journal-title":"Cell Rep Med"},{"key":"5003_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10147-020-01812-9","volume":"26","author":"Y Ota","year":"2021","unstructured":"Ota Y, Noguchi T, Ariji E, Fushimi C, Fuwa N, Harada H, et al. General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis. Int J Clin Oncol. 2021;26:623\u201335.","journal-title":"Int J Clin Oncol"},{"key":"5003_CR25","doi-asserted-by":"publisher","first-page":"113560","DOI":"10.1016\/j.ejca.2024.113560","volume":"200","author":"V Noronha","year":"2024","unstructured":"Noronha V, Patil V, Chaturvedi P, Mathrudev V, Menon N, Bhattacharjee A, et al. Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer. Eur J Cancer. 2024;200:113560.","journal-title":"Eur J Cancer"},{"key":"5003_CR26","doi-asserted-by":"publisher","first-page":"897523","DOI":"10.1155\/2014\/897523","volume":"2014","author":"VK Vincent-Chong","year":"2014","unstructured":"Vincent-Chong VK, Salahshourifar I, Karen-Ng LP, Siow MY, Kallarakkal TG, Ramanathan A, et al. Overexpression of MMP13 is associated with clinical outcomes and poor prognosis in oral squamous cell carcinoma. ScientificWorldJournal. 2014;2014:897523.","journal-title":"ScientificWorldJournal"},{"key":"5003_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/odi.14419","volume":"30","author":"X Chen","year":"2024","unstructured":"Chen X, Lei H, Cheng Y, Fang S, Sun W, Zhang X, et al. CXCL8, MMP12, and MMP13 are common biomarkers of periodontitis and oral squamous cell carcinoma. Oral Dis. 2024;30:390\u2013407.","journal-title":"Oral Dis"},{"key":"5003_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.19760","volume":"5","author":"MA Horlbeck","year":"2016","unstructured":"Horlbeck MA, Gilbert LA, Villalta JE, Adamson B, Pak RA, Chen Y, et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. Elife. 2016;5:e19760.","journal-title":"Elife"},{"key":"5003_CR29","first-page":"964","volume":"8","author":"RM Li","year":"2018","unstructured":"Li RM, Nai MM, Duan SJ, Li SX, Yin BN, An F, et al. Down-expression of GOLM1 enhances the chemo-sensitivity of cervical cancer to methotrexate through modulation of the MMP13\/EMT axis. Am J Cancer Res. 2018;8:964\u201380.","journal-title":"Am J Cancer Res"},{"key":"5003_CR30","doi-asserted-by":"publisher","first-page":"154464","DOI":"10.1016\/j.prp.2023.154464","volume":"245","author":"HS Sugur","year":"2023","unstructured":"Sugur HS, Rao S, Sravya P, Athul Menon K, Arivazhagan A, Mehta B, et al. IRX1 is a novel gene, overexpressed in high-grade IDH-mutant astrocytomas. Pathol Res Pract. 2023;245:154464.","journal-title":"Pathol Res Pract"},{"key":"5003_CR31","doi-asserted-by":"publisher","first-page":"21369","DOI":"10.1002\/jcp.28746","volume":"234","author":"X Zhang","year":"2019","unstructured":"Zhang X, Huang J, You F, Li W, Zou Z. Prognostic and clinicopathological significance of LOXL2 in cancers: a systematic review and meta-analysis. J Cell Physiol. 2019;234:21369\u201379.","journal-title":"J Cell Physiol"},{"key":"5003_CR32","doi-asserted-by":"publisher","first-page":"932167","DOI":"10.3389\/fonc.2022.932167","volume":"12","author":"A Arowolo","year":"2022","unstructured":"Arowolo A, Malebana M, Sunda F, Rhoda C. Proposed cellular function of the human FAM111B protein and dysregulation in fibrosis and cancer. Front Oncol. 2022;12:932167.","journal-title":"Front Oncol"},{"key":"5003_CR33","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"5003_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92.","journal-title":"Nat Rev Dis Primers"},{"key":"5003_CR35","doi-asserted-by":"publisher","first-page":"177368","DOI":"10.1016\/j.ejphar.2025.177368","volume":"993","author":"Y Wang","year":"2025","unstructured":"Wang Y, Sun X, Lu B, Zhang D, Yin Y, Liu S, et al. Current applications, future perspectives and challenges of organoid technology in oral cancer research. Eur J Pharmacol. 2025;993:177368.","journal-title":"Eur J Pharmacol"},{"key":"5003_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41368-024-00324-w","volume":"16","author":"Y Wu","year":"2024","unstructured":"Wu Y, Li X, Liu H, Yang X, Li R, Zhao H, et al. Organoids in the oral and maxillofacial region: present and future. Int J Oral Sci. 2024;16:61.","journal-title":"Int J Oral Sci"},{"key":"5003_CR37","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1177\/00220345241271992","volume":"103","author":"JW Goetz","year":"2024","unstructured":"Goetz JW, Rabinowits G, Kalman N, Villa A. A review of immunotherapy for head and neck cancer. J Dent Res. 2024;103:1185\u201396.","journal-title":"J Dent Res"},{"key":"5003_CR38","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s13402-025-01068-3","volume":"48","author":"N Xue","year":"2025","unstructured":"Xue N, Wang Y, Wang Z, Zeng X, Wang J, Zhang X. Trends in immunotherapy for oral squamous cell carcinoma. Cell Oncol (Dordr). 2025;48:1159\u201379.","journal-title":"Cell Oncol (Dordr)"},{"key":"5003_CR39","doi-asserted-by":"publisher","first-page":"e084176","DOI":"10.1136\/bmjopen-2024-084176","volume":"14","author":"I Vasiliadou","year":"2024","unstructured":"Vasiliadou I, Cattaneo C, Chan PYK, Henley-Smith R, Gregson-Williams H, Collins L, et al. Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO): protocol for a prospective observational study. BMJ Open. 2024;14:e084176.","journal-title":"BMJ Open"},{"key":"5003_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2017.11.021","volume":"414","author":"MZ Jin","year":"2018","unstructured":"Jin MZ, Han RR, Qiu GZ, Ju XC, Lou G, Jin WL. Organoids: an intermediate modeling platform in precision oncology. Cancer Lett. 2018;414:174\u201380.","journal-title":"Cancer Lett"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05003-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:03:19Z","timestamp":1788800599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-05003-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5003"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-05003-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out at Peking University School of Stomatology and was approved by the Biomedical Ethics Committee of Peking University School of Stomatology (PKUSSIRB-202388078). Informed consent was obtained and accepted by all of the patients before enrolment. All methods were performed according to relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"475"}}